INAB · In8bio, Inc.
$1.10
+0.01 (+0.46%)
At close · Sep 2
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's business strategy, its existing cash of $18.0 million as of June 30, 2026 is not anticipated to fund the Company's projected operating expenses and capital expenditure requirements for a period of at least 12 months from the date of issuance of these condensed financial statements, and accordingly, there is substantial doubt about the Company's ability to continue to operate as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$10.75M
Shares
9.86M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding INAB
8 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund | — | 332,083 | $488,162 | 0.05% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 88,865 | $125,300 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 63,611 | $118,953 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 8,320 | $15,558 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 2,040 | $3,815 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 567 | $1,060 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 200 | $282 | 0.00% | Long | 2026-06-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 0 | $0 | 0.00% | Long | 2026-06-30 |
Showing 1–8 of 8 positions
Key facts
CIK
1740279
CUSIP
45674E208
13F (30d)
22 filings
22 filers
Visit website
Investor relations